Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1963 1
1964 1
1977 1
1979 1
1983 1
1984 1
1990 2
1991 1
1993 2
1994 1
1995 1
1996 1
1998 1
2003 3
2004 3
2005 1
2006 2
2007 2
2008 1
2010 4
2011 4
2012 2
2013 1
2014 2
2017 1
2018 1
2019 3
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Copy number signatures and mutational processes in ovarian carcinoma.
Macintyre G, Goranova TE, De Silva D, Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley LA, Hanif A, Wilson C, Dowson S, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Paul J, Supernat A, Millan D, Hoyle A, Bryson G, Nourse C, Mincarelli L, Sanchez LN, Ylstra B, Jimenez-Linan M, Moore L, Hofmann O, Markowetz F, McNeish IA, Brenton JD. Macintyre G, et al. Among authors: hall gd. Nat Genet. 2018 Sep;50(9):1262-1270. doi: 10.1038/s41588-018-0179-8. Epub 2018 Aug 13. Nat Genet. 2018. PMID: 30104763 Free PMC article.
Clinical utility of image-guided peritoneal and omental biopsy.
Spencer JA, Weston MJ, Saidi SA, Wilkinson N, Hall GD. Spencer JA, et al. Among authors: hall gd. Nat Rev Clin Oncol. 2010 Nov;7(11):623-31. doi: 10.1038/nrclinonc.2010.155. Nat Rev Clin Oncol. 2010. PMID: 20981128 Review.
Development of antiangiogenic agents for ovarian cancer.
Collinson FJ, Hall GD, Perren TJ, Jayson GC. Collinson FJ, et al. Among authors: hall gd. Expert Rev Anticancer Ther. 2008 Jan;8(1):21-32. doi: 10.1586/14737140.8.1.21. Expert Rev Anticancer Ther. 2008. PMID: 18095880 Review.
NuMA overexpression in epithelial ovarian cancer.
Brüning-Richardson A, Bond J, Alsiary R, Richardson J, Cairns DA, McCormac L, Hutson R, Burns PA, Wilkinson N, Hall GD, Morrison EE, Bell SM. Brüning-Richardson A, et al. Among authors: hall gd. PLoS One. 2012;7(6):e38945. doi: 10.1371/journal.pone.0038945. Epub 2012 Jun 14. PLoS One. 2012. PMID: 22719996 Free PMC article.
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Oza AM, Matulonis UA, Alvarez Secord A, Nemunaitis J, Roman LD, Blagden SP, Banerjee S, McGuire WP, Ghamande S, Birrer MJ, Fleming GF, Markham MJ, Hirte HW, Provencher DM, Basu B, Kristeleit R, Armstrong DK, Schwartz B, Braly P, Hall GD, Nephew KP, Jueliger S, Oganesian A, Naim S, Hao Y, Keer H, Azab M, Matei D. Oza AM, et al. Among authors: hall gd. Clin Cancer Res. 2020 Mar 1;26(5):1009-1016. doi: 10.1158/1078-0432.CCR-19-1638. Epub 2019 Dec 12. Clin Cancer Res. 2020. PMID: 31831561 Free PMC article. Clinical Trial.
46 results